Literature DB >> 16373297

Bronchial responsiveness to methacholine and adenosine 5'-monophosphate (AMP) in young children with post-infectious bronchiolitis obliterans.

Do Kyun Kim1, Young Yoo, Jinho Yu, Sun Hee Choi, Young Yull Koh.   

Abstract

AIM: Bronchial hyperresponsiveness (BHR) is a characteristic feature of asthma, but it is also frequently demonstrated by children and adults with chronic obstructive lung diseases. BHR is usually measured by bronchial challenges using direct or indirect stimuli. The aim of this study was to compare these two types of bronchial challenge in young children with post-infectious bronchiolitis obliterans (BO).
METHODS: Methacholine and adenosine 5'-monophosphate (AMP) bronchial challenges were performed on preschool children with post-infectious BO (n=18), those with asthma (n=23) and in controls (n=20), using a modified auscultation method. The endpoint was defined as the appearance of wheezing and/or oxygen desaturation.
RESULTS: A positive response to methacholine (an endpoint concentration < or = 8 mg/ml) was observed in 88.9% (16/18) of the patients with post-infectious BO, but a positive response to AMP (an endpoint concentration < or = 200 mg/ml) was observed in only 22.2% (4/18). All patients with asthma responded positively to methacholine, and most (21/23, 91.3%) of them also responded positively to AMP. The majority of the controls were insensitive to both challenges.
CONCLUSION: BHR to methacholine is a frequent, but by no means universal, finding in young children with post-infectious BO, but is usually not accompanied by BHR to AMP.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16373297     DOI: 10.1080/08035250500323756

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  1 in total

1.  Hypoxemia is an independent predictor of bronchiolitis obliterans following respiratory adenoviral infection in children.

Authors:  Pei-Qiong Wu; Xing Li; Wen-Hui Jiang; Gen-Quan Yin; Ai-Hua Lei; Qiang Xiao; Jian-Jun Huang; Zhi-Wei Xie; Li Deng
Journal:  Springerplus       Date:  2016-09-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.